TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36242622

Group type: EXPERIMENTAL
Intervention: Biodegradable hyaluronic acid microneedle patch (BHMN patch)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Needleless patch (NL patch)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups (BHMN patch and NL patch)
Number of subjects: 15
Study: 33397869

Group type: EXPERIMENTAL
Intervention: Mitral valve replacement with preservation of mitral subvalvular apparatus (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional mitral valve replacement (Group B)
Number of subjects: 60
Study: 32658775

Group type: EXPERIMENTAL
Intervention: One-class support vector machine (OCSVM) for evaluating mental workload during driving tasks
Number of subjects: 12

Group type: COMPARATOR
Intervention: N-back task with five difficulty levels (none to 3-back)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Driving simulator (DS)
Number of subjects: 12
Study: 35700203

Group type: EXPERIMENTAL
Intervention: Jholmal (locally prepared bio-fertilizer and pesticides)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Straw mulching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Farmer's business usual practice (control for jholmal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-mulched trials (control for straw mulching)
Number of subjects: 0
Study: 34217127

Group type: EXPERIMENTAL
Intervention: Aromatherapy with 3% lavender oil (2.5 cc, gentle massage for 10 min every night for a month)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (n = 26)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (n = 26)
Number of subjects: 75
Study: 33909914

Group type: EXPERIMENTAL
Intervention: RSD with perioscope
Number of subjects: 38
Study: 34492725

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IHMs)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 36473040

Group type: COMPARATOR
Intervention: Opioid anesthesia (Fentanyl group - FG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Opioid free anesthesia (Opioid Free Anesthesia Group - OFAG)
Number of subjects: 80
Study: 33412107

Group type: EXPERIMENTAL
Intervention: Composite type‐2 biomarker strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Symptom–risk‐based algorithm
Number of subjects: 0
Study: 32133910

Group type: EXPERIMENTAL
Intervention: 7 mg nicotine patch
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 2 g of L-tyrosine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 33843562

Group type: EXPERIMENTAL
Intervention: Multicomponent, kindergarten-based, family-involved intervention
Number of subjects: 6268

Group type: EXPERIMENTAL
Intervention: Parental characteristics (underestimation of children's weight status, parental overweight, mothers' pre-pregnancy overweight/obesity)
Number of subjects: 6268
Study: 34580104

Group type: EXPERIMENTAL
Intervention: Informed consent procedures in cluster randomised trials (CRTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Framework for informed consent in CRTs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Examples of CRTs
Number of subjects: 0
Study: 35500883

Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 20

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 20
Study: 33870956

Group type: EXPERIMENTAL
Intervention: Personal motivation calls
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Automated motivational calls
Number of subjects: 260

Group type: COMPARATOR
Intervention: No calls
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Self-efficacy change at 24 weeks
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Psychological outcome realizations at 24 weeks
Number of subjects: 260
Study: 33880691

Group type: EXPERIMENTAL
Intervention: Familias Unidas preventive intervention
Number of subjects: 746
Study: 35094123

Group type: EXPERIMENTAL
Intervention: Isometric exercise training (IET)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control period
Number of subjects: 24
Study: 36205998

Group type: EXPERIMENTAL
Intervention: Kidney transplant
Number of subjects: 4445

Group type: COMPARATOR
Intervention: Continued dialysis
Number of subjects: 4445
Study: 33917668

Group type: EXPERIMENTAL
Intervention: Pre-competition massage on one leg (experimental)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No intervention on the opposite leg (control)
Number of subjects: 30
Study: 32143877

Group type: EXPERIMENTAL
Intervention: Threshold inspiratory muscle training (TIMT) at 30% of maximal inspiratory pressure (MIP) for 15 min, twice per day for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group performing at lowest pressure without change in threshold pressure
Number of subjects: 30
Study: 34768288

Group type: EXPERIMENTAL
Intervention: Disposable endoscope
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional endoscope
Number of subjects: 144
Study: 34219267

Group type: EXPERIMENTAL
Intervention: Quercetin (50 μM)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (frozen-thawed semen without Quercetin)
Number of subjects: 25
Study: 36013125

Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME) using a Hyrax type expander
Number of subjects: 32

Group type: COMPARATOR
Intervention: Slow Maxillary Expansion (SME) using a Leaf Expander (LE)
Number of subjects: 32
Study: 33875284

Group type: EXPERIMENTAL
Intervention: Total parietal peritonectomy (TPP) during interval cytoreductive surgery (CRS)
Number of subjects: 70
Study: 35775453

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current care
Number of subjects: 0
Study: 32126031

Group type: EXPERIMENTAL
Intervention: Symfony extended depth-of-focus IOL
Number of subjects: 30

Group type: COMPARATOR
Intervention: AT LISA tri 839MP IOL
Number of subjects: 30
Study: 33971132

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 320
Study: 32115027

Group type: EXPERIMENTAL
Intervention: Shovel beak extending 0-1 mm (SB0-1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Shovel beak extending 1-2 mm (SB1-2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Shovel beak extending 2-3 mm (SB2-3)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Shovel beak extending 3-4 mm (SB3-4)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Shovel beak extending >4 mm (SB > 4)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cracks (Cr)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bubbles (B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Flush beak (control)
Number of subjects: 80
Study: 33516964

Group type: EXPERIMENTAL
Intervention: HeartMath app-based HRV biofeedback
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 52
Study: 32086111

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 66

Group type: COMPARATOR
Intervention: Traditional IBS diet
Number of subjects: 66
Study: 33860484

Group type: EXPERIMENTAL
Intervention: Early double-guidewire (EDG) technique
Number of subjects: 142

Group type: COMPARATOR
Intervention: Repeated single-guidewire (RSG) technique
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 142
Study: 34418898

Group type: EXPERIMENTAL
Intervention: Combined training (CT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 23
Study: 32437507

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks until disease progression, unacceptable toxic effects, or death
Number of subjects: 369

Group type: COMPARATOR
Intervention: Bevacizumab 10 mg/kg every 2 weeks until disease progression, unacceptable toxic effects, or death
Number of subjects: 369
Study: 35170493

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 139
Study: 33846727

Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 100% of the estimated rumen‐degradable protein requirement (F) provided daily (D)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 50% of the estimated rumen‐degradable protein requirement (H) provided daily (D)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 100% (F) or 50% (H) provided once every 5 days (5D)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 100% (F) or 50% (H) provided once every 10 days (10D)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (non‐supplemented)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: All supplements provided
Number of subjects: 7
Study: 35274585

Group type: EXPERIMENTAL
Intervention: Home monitoring (HM) of symptoms measured by the Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD‐CRISS) and forced expiratory volume in one second (FEV1)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Home monitoring (HM)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Routine clinical care (RC)
Number of subjects: 88
Study: 32854869

Group type: EXPERIMENTAL
Intervention: Systemic treatment of SCD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Malocclusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unusual orofacial findings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Penicillin, vaccines, and hydroxyurea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comprehensive oral health care
Number of subjects: 0
Study: 34993933

Group type: EXPERIMENTAL
Intervention: Eflapegrastim (1.1, 3.3, 10, 45, 135, and 270 μg/kg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Pegfilgrastim (6 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 33764609

Group type: EXPERIMENTAL
Intervention: NaOCl + EDTA + PIPS (EDTA)
Number of subjects: 144

Group type: COMPARATOR
Intervention: NaOCl + EDTA + PIPS (distilled water)
Number of subjects: 144

Group type: COMPARATOR
Intervention: NaOCl + PIPS (EDTA)
Number of subjects: 144

Group type: COMPARATOR
Intervention: NaOCl + PIPS (distilled water)
Number of subjects: 144

Group type: COMPARATOR
Intervention: NaOCl + EDTA
Number of subjects: 144

Group type: COMPARATOR
Intervention: NaOCl
Number of subjects: 144
Study: 32702567

Group type: EXPERIMENTAL
Intervention: Corrected nose-earlobe-xiphoid distance formula
Number of subjects: 218
Study: 35664355

Group type: EXPERIMENTAL
Intervention: GAD-alum treatment
Number of subjects: 26
Study: 34171973

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 32756094

Group type: EXPERIMENTAL
Intervention: Pureed rice with gelling agent
Number of subjects: 62

Group type: COMPARATOR
Intervention: Pureed rice without gelling agent
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Older patients (irrespective of gelling agent presence)
Number of subjects: 62
Study: 35346925

Group type: EXPERIMENTAL
Intervention: Viewing quality measures with peer comparisons before choosing certification activities (intervention group)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Standard selection of certification activities without prior viewing of quality measures (control group)
Number of subjects: 254
Study: 34396066

Group type: EXPERIMENTAL
Intervention: 3MTM CobanTM 2 layer system bandaging
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional multi-layer short-stretch bandaging
Number of subjects: 60
Study: 33548380

Group type: EXPERIMENTAL
Intervention: High-polyphenolic extra virgin olive oil (EVOO), 50 mL
Number of subjects: 20

Group type: COMPARATOR
Intervention: Refined olive oil without polyphenols, 50 mL
Number of subjects: 20
Study: 616520941

Group type: EXPERIMENTAL
Intervention: E/C/F/TDF (co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
Number of subjects: 429

Group type: COMPARATOR
Intervention: PI + RTV + TVD (multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF)
Number of subjects: 429
Study: 36153205

Group type: EXPERIMENTAL
Intervention: Voice treatment with Acapella Choice device plus vocal hygiene program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Voice treatment with Water resistance therapy plus vocal hygiene program
Number of subjects: 30
Study: 35083939

Group type: EXPERIMENTAL
Intervention: 12-week, 30-min morning jogging intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no physical exercise intervention)
Number of subjects: 0
Study: 34337965

Group type: EXPERIMENTAL
Intervention: Omeprazole (1 mg/kg, PO, q 12 h)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Famotidine (1 mg/kg, PO, q 12 h)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (lactose; PO, q 12 h)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33715054

Group type: EXPERIMENTAL
Intervention: Autogenous bone graft alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-tricalcium phosphate (β-TCP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: β-TCP + autogenous bone graft 1:1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bioactive glass
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bioactive glass + autogenous bone graft 1:1
Number of subjects: 0
Study: 36128956

Group type: EXPERIMENTAL
Intervention: ACURATE neo
Number of subjects: 648

Group type: COMPARATOR
Intervention: CoreValve Evolut
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: New LBBB
Number of subjects: 648
Study: 32548904

Group type: EXPERIMENTAL
Intervention: Ultrapulsed CO2 laser debridement (LT group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Traditional sharp instrument/surgical debridement (RT group)
Number of subjects: 54
Study: 33052809

Group type: EXPERIMENTAL
Intervention: Aerosol box
Number of subjects: 48

Group type: COMPARATOR
Intervention: No aerosol box
Number of subjects: 48
Study: 35656881

Group type: EXPERIMENTAL
Intervention: Prone EVLP
Number of subjects: 10

Group type: COMPARATOR
Intervention: Supine EVLP
Number of subjects: 10
Study: 34118980

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 33228614

Group type: EXPERIMENTAL
Intervention: Not applicable (observational study)
Number of subjects: 592
Study: 33548363

Group type: EXPERIMENTAL
Intervention: Promotora-delivered one-on-one breast and cervical cancer screening education and navigation calls
Number of subjects: 627
Study: 32423462

Group type: EXPERIMENTAL
Intervention: Extended infusion (EI) of β-lactam antibiotics (BLA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent infusion (II) of β-lactam antibiotics (BLA)
Number of subjects: 0
Study: 35170739

Group type: EXPERIMENTAL
Intervention: SELEVER interventions (groups 1 + 2)
Number of subjects: 1054

Group type: COMPARATOR
Intervention: SELEVER
Number of subjects: 1054
Study: 32544346

Group type: EXPERIMENTAL
Intervention: Motivational plus implementation intentions intervention
Number of subjects: 157

Group type: COMPARATOR
Intervention: Implementation intentions condition
Number of subjects: 157

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 157
Study: 32772921

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 678

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 678
Study: 34472497

Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: General anesthesia (both xenon and sevoflurane)
Number of subjects: 24
Study: 36302049

Group type: EXPERIMENTAL
Intervention: Explicit glycated haemoglobin intervention targets 5mmol/mol above current glycated haemoglobin readings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit glycated haemoglobin intervention targets 5mmol/mol below current glycated haemoglobin readings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline validated psychometric questionnaires
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative semi-structured interviews
Number of subjects: 0
Study: 32578258

Group type: EXPERIMENTAL
Intervention: Group Teen Triple P Program (8 weeks)
Number of subjects: 76
Study: 35657063

Group type: EXPERIMENTAL
Intervention: Compression Garment (CG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Noncompression Group (NCG)
Number of subjects: 75
Study: 32712762

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg−1 bolus followed by 10 mcg kg−1 min−1 infusion
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg kg−1 bolus followed by 5 mcg kg−1 min−1 infusion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no ketamine)
Number of subjects: 27
Study: 34380099

Group type: EXPERIMENTAL
Intervention: Active-tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 20
Study: 33236202

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined fractional CO2 with PRP
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined fractional CO2 with NB-UVB
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined fractional CO2 with PRP and NB-UVB
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 35082225

Group type: EXPERIMENTAL
Intervention: Conventional dentures (CDs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Digital dentures (DDs)
Number of subjects: 0
Study: 33125282

Group type: EXPERIMENTAL
Intervention: Newtom‐5G
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Orthophos‐SL
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cranex‐3Dx (patient standing/sitting)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: X1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Supine position with foam headrest
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Younger children
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preferred unit with supine position and foam headrest
Number of subjects: 40
Study: 35693290

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study: 32702911

Group type: EXPERIMENTAL
Intervention: Combination therapy with electroacupuncture (EA) and computerized cognitive rehabilitation treatment (CCRT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination therapy with transcranial direct current stimulation (tDCS) and computerized cognitive rehabilitation treatment (CCRT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Computerized cognitive rehabilitation treatment (CCRT) alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination therapy with EA and CCRT
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination therapy with tDCS and CCRT
Number of subjects: 45

Group type: COMPARATOR
Intervention: CCRT alone
Number of subjects: 45
Study: 36456003

Group type: EXPERIMENTAL
Intervention: Digital platform (Prisma) for interdisciplinary consultation
Number of subjects: 1008
Study: 33039154

Group type: EXPERIMENTAL
Intervention: Vitamin D levels ≤16 ng/mL for GDM
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels 16–26 ng/mL for GDM
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels >26 ng/mL for GDM
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels ≤15 ng/mL for preterm delivery
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels 15–21 ng/mL for preterm delivery
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels >21 ng/mL for preterm delivery
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels ≤15 ng/mL for preeclampsia
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels 15–23 ng/mL for preeclampsia
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Vitamin D levels >23 ng/mL for preeclampsia
Number of subjects: 1763
Study: 35994896

Group type: EXPERIMENTAL
Intervention: Menopausal hormone therapy (MHT) containing 1 or 2 mg of estradiol and cyclical 10 mg dydrogesterone for one year
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Menopausal hormone therapy (MHT)
Number of subjects: 27
Study: 34510180

Group type: EXPERIMENTAL
Intervention: OWN SUPP
Number of subjects: 52

Group type: COMPARATOR
Intervention: STER SUPP
Number of subjects: 52
Study: 35618961

Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor (CGF)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Collagen Membrane (CM)
Number of subjects: 51
Study: 33493703

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Bupropion and Placebo (overall population)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Bupropion and Placebo (African American women)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Bupropion and Placebo (women with lower severity of nicotine dependence)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Bupropion and Placebo (women with opioid use disorder)
Number of subjects: 129
Study: 32823594

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg·kg−1·body mass)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 33331980

Group type: EXPERIMENTAL
Intervention: FP-025 (API-in-Capsule) 800 mg single ascending dose
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: FP-025 (ASD-in-Capsule) multiple ascending doses (100, 200, 400 mg, twice daily for 8 days)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: FP-025 (ASD-in-Capsule)
Number of subjects: 96